Cargando…
Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges
Pulmonary arterial hypertension (PAH) is a rare, chronic disease of the pulmonary vasculature that is associated with poor outcomes. Its pathogenesis is multifactorial and includes micro-RNA (miRNA) deregulation. The understanding of the role of miRNAs in PAH is expanding quickly, and it is increasi...
Autores principales: | Santos-Ferreira, Cátia A., Abreu, Mónica T., Marques, Carla I., Gonçalves, Lino M., Baptista, Rui, Girão, Henrique M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691282/ https://www.ncbi.nlm.nih.gov/pubmed/33294743 http://dx.doi.org/10.1016/j.jacbts.2020.07.008 |
Ejemplares similares
-
Opportunities and challenges in
psychopharmacology
por: Schulz, Pierre
Publicado: (2019) -
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022) -
lncRNA/MicroRNA interactions in the vasculature
por: Ballantyne, MD, et al.
Publicado: (2016) -
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms
por: Trusheim, MR, et al.
Publicado: (2016) -
Genetic variation and pharmacogenomics: concepts, facts, and challenges
por: Hoehe, Margret R., et al.
Publicado: (2004)